Novartis
NVS
NVS
925 hedge funds and large institutions have $21.4B invested in Novartis in 2015 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 335 increasing their positions, 349 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
3% less funds holding in top 10
Funds holding in top 10: 61 → 59 (-2)
7% less capital invested
Capital invested by funds: $22.9B → $21.4B (-$1.51B)
19% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 53
Holders
925
Holding in Top 10
59
Calls
$69.6M
Puts
$71M
Top Buyers
| 1 | +$312M | |
| 2 | +$306M | |
| 3 | +$306M | |
| 4 |
IC
Institutional Capital
Chicago,
Illinois
|
+$210M |
| 5 |
MNA
Manning & Napier Advisors
Fairport,
New York
|
+$137M |
Top Sellers
| 1 | -$368M | |
| 2 | -$207M | |
| 3 | -$122M | |
| 4 |
BG
Bahl & Gaynor
Cincinnati,
Ohio
|
-$78.6M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$57.7M |